11.02
+0.42(+3.96%)
Currency In USD
| Previous Close | 10.6 |
| Open | 10.38 |
| Day High | 11.02 |
| Day Low | 10.36 |
| 52-Week High | 11.38 |
| 52-Week Low | 6.55 |
| Volume | 8,585 |
| Average Volume | 27,887 |
| Market Cap | 54.68M |
| PE | -122.44 |
| EPS | -0.09 |
| Moving Average 50 Days | 9.62 |
| Moving Average 200 Days | 8.48 |
| Change | 0.42 |
If you invested $1000 in Daxor Corporation (DXR) 10 years ago, it would be worth $1,688.52 as of August 18, 2025 at a share price of $10.52. Whereas If you bought $1000 worth of Daxor Corporation (DXR) shares 5 years ago, it would be worth $653.42 as of August 18, 2025 at a share price of $10.52.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available
GlobeNewswire Inc.
Aug 12, 2025 12:00 PM GMT
The celebration marks a major milestone for the patent-pending, next-generation, rapid, compact, and hand-held Daxor BVA™. Oak Ridge, TN, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measureme
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System
GlobeNewswire Inc.
Aug 07, 2025 11:55 AM GMT
Management Expects High Demand Driven by Speed, Simplicity, and Clinical Precision Oak Ridge, TN, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces FDA 510(k
Daxor’s Blood Volume Analysis Technology Accelerates Market Penetration with Three New Facility Adoptions
GlobeNewswire Inc.
Jul 22, 2025 12:00 PM GMT
Continued Integration of Daxor’s ezBVA Lab Service and On-Site Analyzers Fuels Positive Outlook Oak Ridge, TN, July 22, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces th